Company

Neuromity Therapeutics, Inc.

Pharmaceutical Manufacturing Boston, Massachusetts, United States 6 employees

Employees: 6

www.neuromity.com LinkedIn

Neuromity Therapeutics, Inc. Overview

Headquarters: Boston, Massachusetts, United States
Website: www.neuromity.com
Industry: Pharmaceutical Manufacturing
Employees: 6
Founded: 2021
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

Keywords

Reno

About Neuromity Therapeutics, Inc.

Neuromity is pioneering treatments for neurological disorders using deuterium-enabled chiral switching (DECS). Our lead program, NTY-184 (deuterium-stabilized S-bupropion), is being developed initially for major depressive disorder (MDD) as an NCE with new composition of matter IP via an expedited and derisked 505(b)(2) regulatory pathway.